- Home
- DAC vs OCUL Comparison
DAC vs OCUL Comparison
Compare DAC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAC | OCUL |
|---|---|---|
| Founded | 1972 | 2006 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DAC | OCUL |
|---|---|---|
| Price | $117.30 | $9.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $112.50 | $23.56 |
| AVG Volume (30 Days) | 51.6K | ★ 3.3M |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | N/A | $7.93 |
| Revenue Next Year | N/A | $96.07 |
| P/E Ratio | $4.01 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $79.48 | $6.23 |
| 52 Week High | $120.00 | $16.44 |
Technical Indicators
Market Signals| Indicator | DAC | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 55.86 | 55.05 |
| Support Level | $91.64 | $8.36 |
| Resistance Level | $118.58 | $9.86 |
| Average True Range (ATR) | 2.73 | 0.50 |
| MACD | -0.12 | 0.12 |
| Stochastic Oscillator | 61.77 | 76.51 |
Price Performance
Historical ComparisonAbout DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.